Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed…
HiBob Named Best HR Management Software in the UK for 2026
Ionik Announces 30-Day Extension of Senior Debt Facility
NTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow
Voghion Expands Beyond Fashion to Build a One-Stop Lifestyle Platform Across Europe